Portal de Periódicos da CAPES

An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.

1992; Lippincott Williams & Wilkins; Volume: 86; Issue: 2 Linguagem: Inglês

10.1161/01.cir.86.2.683

1524-4539

Eugene Braunwald, Christopher P. Cannon, Carolyn H. McCabe,

Cardiac, Anesthesia and Surgical Outcomes

HomeCirculationVol. 86, No. 2An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAn approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. E Braunwald, C P Cannon and C H McCabe E BraunwaldE Braunwald Department of Medicine, Harvard Medical School, Boston, MA. , C P CannonC P Cannon Department of Medicine, Harvard Medical School, Boston, MA. and C H McCabeC H McCabe Department of Medicine, Harvard Medical School, Boston, MA. Originally published1 Aug 1992https://doi.org/10.1161/01.CIR.86.2.683Circulation. 1992;86:683–687 Previous Back to top Next FiguresReferencesRelatedDetailsCited By McCarthy C and Januzzi J (2022) Periprocedural MI as an Endpoint in Clinical Trials, Journal of the American College of Cardiology, 10.1016/j.jacc.2021.11.046, 79:6, (527-529), Online publication date: 1-Feb-2022. Jang A, Kim M, Lee J, Seo J, Shin Y, Oh P, Suh S, Lee K, Kang W, Ahn T and Han S (2022) Real-World Treatment Selection Factors and 7-Year Clinical Outcomes between Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Left Main Disease, Journal of Clinical Medicine, 10.3390/jcm11030503, 11:3, (503) Udogwu U, Howe A, Frey K, Isaac M, Connelly D, Marinos D, Baker M, Castillo R, Slobogean G, O'Toole R and O'Hara N (2019) A patient-centered composite endpoint weighting technique for orthopaedic trauma research, BMC Medical Research Methodology, 10.1186/s12874-019-0885-7, 19:1, Online publication date: 1-Dec-2019. Matsouaka R, Singhal A and Betensky R (2016) An optimal Wilcoxon–Mann–Whitney test of mortality and a continuous outcome, Statistical Methods in Medical Research, 10.1177/0962280216680524, 27:8, (2384-2400), Online publication date: 1-Aug-2018. Tan N, Ali S, Lebovic G, Mamdani M, Laupacis A and Yan A (2017) Temporal Trends in Use of Composite End Points in Major Cardiovascular Randomized Clinical Trials in Prominent Medical Journals, Circulation: Cardiovascular Quality and Outcomes, 10:10, Online publication date: 1-Oct-2017. Mao L and Lin D (2015) Semiparametric regression for the weighted composite endpoint of recurrent and terminal events, Biostatistics, 10.1093/biostatistics/kxv050, 17:2, (390-403), Online publication date: 1-Apr-2016. Bakal J, Westerhout C and Armstrong P (2012) Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials, Statistical Methods in Medical Research, 10.1177/0962280211436004, 24:6, (980-988), Online publication date: 1-Dec-2015. Pandit J, Gupta V, Boyer N, Yeghiazarians Y, Ports T and Boyle A (2014) Patient and physician perspectives on outcomes weighting in revascularization. The POWR study, International Journal of Cardiology, 10.1016/j.ijcard.2014.08.096, 177:2, (513-514), Online publication date: 1-Dec-2014. Chang S, Newton P, Inglis S, Luckett T, Krum H, Macdonald P and Davidson P (2012) Are all outcomes in chronic heart failure rated equally? An argument for a patient-centred approach to outcome assessment, Heart Failure Reviews, 10.1007/s10741-012-9369-0, 19:2, (153-162), Online publication date: 1-Mar-2014. Busse J, Bhandari M, Ferreira-González I, Montori V and Guyatt G (2012) Use and Interpretation of Composite End Points in Orthopaedic Trials, Journal of Bone and Joint Surgery, 10.2106/JBJS.K.01287, 94:Supplement_1, (65-69), Online publication date: 18-Jul-2012. Mantz J, Samama C, Tubach F, Devereaux P, Collet J, Albaladejo P, Cholley B, Nizard R, Barré J, Piriou V, Poirier N, Mignon A, Schlumberger S, Longrois D, Aubrun F, Farèse M, Ravaud P and Steg P (2011) Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial †, British Journal of Anaesthesia, 10.1093/bja/aer274, 107:6, (899-910), Online publication date: 1-Dec-2011. Armstrong P, Westerhout C, Van de Werf F, Califf R, Welsh R, Wilcox R and Bakal J (2011) Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial, American Heart Journal, 10.1016/j.ahj.2010.12.026, 161:5, (848-854), Online publication date: 1-May-2011. Dechartres A, Albaladejo P, Mantz J, Samama C, Collet J, Steg P, Ravaud P, Tubach F and Tractenberg R (2011) Delphi-Consensus Weights for Ischemic and Bleeding Events to Be Included in a Composite Outcome for RCTs in Thrombosis Prevention, PLoS ONE, 10.1371/journal.pone.0018461, 6:4, (e18461) Pogue J, Thabane L, Devereaux P and Yusuf S (2010) Testing for heterogeneity among the components of a binary composite outcome in a clinical trial, BMC Medical Research Methodology, 10.1186/1471-2288-10-49, 10:1, Online publication date: 1-Dec-2010. Discigil B, Chua Y, Pearson P, Evora P, Celotto A and Schaff H (2009) Comparisons of the release of vasodilator substances from left and right cardiac chambers of the isolated perfused rabbit heart: Implications for intraventricular thrombus formation, Nitric Oxide, 10.1016/j.niox.2009.02.003, 20:4, (259-263), Online publication date: 1-Jun-2009. Ferreira-González I, Permanyer-Miralda G, Busse J, Bryant D, Montori V, Alonso-Coello P, Walter S and Guyatt G (2007) Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2006.10.020, 60:7, (651-657), Online publication date: 1-Jul-2007. Zhao Y, Grambsch P and Neaton J (2016) A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome, Clinical Trials, 10.1177/1740774507076936, 4:2, (140-153), Online publication date: 1-Apr-2007. Attie F (2002) Reply, Journal of the American College of Cardiology, 10.1016/S0735-1097(02)01921-6, 40:1, (205), Online publication date: 1-Jul-2002. Skali H, Solomon S and Pfeffer M (2002) Are we asking too much of our trials?, American Heart Journal, 10.1067/mhj.2002.119771, 143:1, (1-3), Online publication date: 1-Jan-2002. Zeymer U, Suryapranata H, Monassier J, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schröder R, Tiemann R, Machnig T and Neuhaus K (2001) The Na+/H+exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction11This manuscript is dedicated to the memory of Karl-Ludwig Neuhaus (1944–2000)., Journal of the American College of Cardiology, 10.1016/S0735-1097(01)01608-4, 38:6, (E1644-E1650), Online publication date: 1-Nov-2001. Bhatt D, Hirsch A, Ringleb P, Hacke W and Topol E (2000) Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin, American Heart Journal, 10.1067/mhj.2000.108239, 140:1, (67-73), Online publication date: 1-Jul-2000. Ellis S, da Silva E, Spaulding C, Nobuyoshi M, Weiner B and Talley J (2000) Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences, American Heart Journal, 10.1067/mhj.2000.106624, 139:6, (1046-1053), Online publication date: 1-Jun-2000. O'Connor C, Gattis W and Ryan T (2000) The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials, American Heart Journal, 10.1016/S0002-8703(00)90062-0, 139:4, (S143-S154), Online publication date: 1-Apr-2000. Neuhaus K, Molhoek G, Zeymer U, Tebbe U, Wegscheider K, Schröder R, Camez A, Laarman G, Grollier G, Lok D, Kuckuck H and Lazarus P (1999) Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction, Journal of the American College of Cardiology, 10.1016/S0735-1097(99)00319-8, 34:4, (966-973), Online publication date: 1-Oct-1999. Zeymer U and Neuhaus K (1999) New Thrombolytic Agents Management of Acute Coronary Syndromes, 10.1007/978-1-59259-731-4_10, (243-265), . Cannon C and Loscalzo J (1999) Thrombolytic and Antithrombotic Therapies for Acute Coronary Syndromes Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_8, (142-175), . Grines C, Marsalese D, Brodie B, Griffin J, Donohue B, Costantini C, Balestrini C, Stone G, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Sachs D, Grines L and O'Neill W (1998) Safety and Cost-Effectiveness of Early Discharge After Primary Angioplasty in Low Risk Patients With Acute Myocardial Infarction 11Research funding for this study was provided by unrestricted grants from Advanced Cardiovascular Systems, Santa Clara, California; Mallinckrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey., Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00031-X, 31:5, (967-972), Online publication date: 1-Apr-1998. White R (2016) Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update, Asian Cardiovascular and Thoracic Annals, 10.1177/021849239800600102, 6:1, (3-10), Online publication date: 1-Mar-1998. Cannon C (1997) Clinical perspectives on the use of composite endpoints, Controlled Clinical Trials, 10.1016/S0197-2456(97)00005-6, 18:6, (517-529), Online publication date: 1-Dec-1997. Cannon C, Sharis P, Schweiger M, McCabe C, Diver D, Shah P, Sequeira R, Greene R, Perritt R, Poole W and Braunwald E (1997) Prospective Validation of a Composite End Point in Thrombolytic Trials of Acute Myocardial Infarction (TIMI 4 and 5), The American Journal of Cardiology, 10.1016/S0002-9149(97)00497-9, 80:6, (696-699), Online publication date: 1-Sep-1997. Birnbaum Y, Kloner R, Sclarovsky S, Cannon C, McCabe C, Davis V, Zaret B, Wackers F and Braunwald E (1996) Distortion of the Terminal Portion of the QRS on the Admission Electrocardiogram in Acute Myocardial Infarction and Correlation With Infarct Size and Long-Term Prognosis (Thrombolysis In Myocardial Infarction 4 Trial)**This study was supported in part by a grant from SmithKline Beecham, Philadelphia, Pennsylvania., The American Journal of Cardiology, 10.1016/S0002-9149(96)00326-8, 78:4, (396-403), Online publication date: 1-Aug-1996. Schröder R, Wegscheider K, Schröder K, Dissmann R and Meyer-Sabellek W (1995) Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens, Journal of the American College of Cardiology, 10.1016/0735-1097(95)00372-X, 26:7, (1657-1664), Online publication date: 1-Dec-1995. Collins R, Baigent C and Peto R (1995) Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression., Heart, 10.1136/hrt.74.5.573-a, 74:5, (573-574), Online publication date: 1-Nov-1995. Mueller H, Forman S, Menegus M, Cohen L, Knatterud G and Braunwald E (1995) Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial, Journal of the American College of Cardiology, 10.1016/0735-1097(95)00270-1, 26:4, (900-907), Online publication date: 1-Oct-1995. Talley J (1995) NEWS & VIEWS, Journal of Interventional Cardiology, 10.1111/j.1540-8183.1995.tb00551.x, 8:3, (329-334), Online publication date: 1-Jun-1995. CANNON C, BRAUNWALD E, McCABE C and ANTMAN E (1995) The Thrombolysis In Myocardial Infarction (TIMI) Trials: The First Decade, Journal of Interventional Cardiology, 10.1111/j.1540-8183.1995.tb00526.x, 8:2, (117-135), Online publication date: 1-Apr-1995. Velury V, Ma Y, Hurley T, Hebert J, Becker C and Becker R (1995) Clinical utility of electrocardiographic ST-segment area for predicting unsatisfactory outcomes following thrombolytic therapy, Journal of Thrombosis and Thrombolysis, 10.1007/BF01063162, 2:1, (51-56), . Cannon C, McCabe C, Diver D, Herson S, Greene R, Shah P, Sequeira R, Leya F, Kirshenbaum J, Magorien R, Palmeri S, Davis V, Gibson C, Poole W and Braunwald E (1994) Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial, Journal of the American College of Cardiology, 10.1016/0735-1097(94)90163-5, 24:7, (1602-1610), Online publication date: 1-Dec-1994. Spertus J, Winder J, Dewhurst T, Deyo R and Fihn S (1994) Monitoring the quality of life in patients with coronary artery disease, The American Journal of Cardiology, 10.1016/0002-9149(94)90555-X, 74:12, (1240-1244), Online publication date: 1-Dec-1994. Fears R and Poste G (1994) Obstacles to the development of novel thrombolytic agents for acute myocardial infarction therapy: Is the good the enemy of the best?, Fibrinolysis, 10.1016/0268-9499(94)90045-0, 8:4, (203-213), Online publication date: 1-Jul-1994. Cannon C, McCabe C and Braunwald E (1994) The Thrombolysis in Myocardial Infarction (TIMI) Trial The Modern Era of Coronary Thrombolysis, 10.1007/978-1-4615-2618-6_5, (53-67), . Braunwald E, Cannon C and McCabe C (1993) Use of composite endpoints in thrombolysis trials of acute myocardial infarction, The American Journal of Cardiology, 10.1016/0002-9149(93)90101-H, 72:19, (G3-G12), Online publication date: 1-Dec-1993. August 1, 1992Vol 86, Issue 2 Advertisement Article InformationMetrics Copyright © 1992 by American Heart Associationhttps://doi.org/10.1161/01.CIR.86.2.683 Originally publishedAugust 1, 1992 PDF download Advertisement